Martine Rothblatt
2017
In 2017, Martine Rothblatt earned a total compensation of $37.1M as Chairman and Chief Executive Officer at United Therapeutics, a 141% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,239,653 |
|---|---|
| Non-Equity Incentive Plan | $1,598,163 |
| Option Awards | $33,122,078 |
| Salary | $1,163,707 |
| Other | $9,600 |
| Total | $37,133,201 |
Rothblatt received $33.1M in option awards, accounting for 89% of the total pay in 2017.
Rothblatt also received $1.2M of change in pension value and nonqualified deferred compensation earnings, $1.6M in non-equity incentive plan, $1.2M in salary and $9.6K in other compensation.
Rankings
In 2017, Martine Rothblatt's compensation ranked 45th out of 14,666 executives tracked by ExecPay. In other words, Rothblatt earned more than 99.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 45 out of 14,666 | 100th |
Division Manufacturing | 8 out of 5,772 | 100th |
Major group Chemicals And Allied Products | 2 out of 2,075 | 100th |
Industry group Drugs | 2 out of 1,731 | 100th |
Industry Pharmaceutical Preparations | 2 out of 1,333 | 100th |
Source: SEC filing on April 27, 2018.
Rothblatt's colleagues
We found three more compensation records of executives who worked with Martine Rothblatt at United Therapeutics in 2017.